Patents Assigned to J-Pharma Co., Ltd
  • Publication number: 20100112596
    Abstract: The present invention relates to kits and methods for determining (diagnosing) prostate cancer malignancy and to predict patient prognoses. In addition to the Gleason's classification and the TMN classification, the invention kit and methods provide improved procedures with molecular markers. These new diagnostic methods provide methods capable of determining prostate cancer malignancy more accurately and easily through combination with the Gleason's classification via biopsies at an early stage before surgical operation; even when specimens taken through a fine needle examination are used instead of specimens extracted during a surgical operation.
    Type: Application
    Filed: February 6, 2007
    Publication date: May 6, 2010
    Applicant: J-PHARMA CO., LTD.
    Inventors: Hitoshi Endou, Isao Okayasu, Takeshi Sakata
  • Patent number: 7666999
    Abstract: A novel amino acid transporter molecule mediating transportation of amino acids, which are nutrients essentially required in the survival and proliferation of various normal cells constituting a living body and various pathology-associated abnormal cells such as tumor cells, into cells and being expressed specifically in tumor cells compared with normal cells; and drugs for treating various pathogenic conditions such as tumor (cancer) which are obtained by identifying and isolating the above amino acid transporter molecule and identifying a substance capable of inhibiting the biological activity and/or expression of this molecule. Intensive studies were made to identify a tumor cell membrane surface molecule associating or interacting with a cell membrane surface 4F2hc molecule seemingly playing an important role in the activation of an unknown amino acid transporter.
    Type: Grant
    Filed: August 5, 2004
    Date of Patent: February 23, 2010
    Assignee: J-Pharma Co., Ltd.
    Inventors: Hitoshi Endou, Yoshikatsu Kanai
  • Publication number: 20090280191
    Abstract: The present invention provides agents for preventing, improving or treating phosphorus-related disorders and oral preparations; agents high in biosafety and phosphorus adsorptive power, which contain, as an active ingredient, ferric hydroxide as produced under such conditions that a ferrous species is present.
    Type: Application
    Filed: June 29, 2006
    Publication date: November 12, 2009
    Applicant: J-PHARMA CO., LTD.
    Inventors: Hitoshi Endou, Tomotaka Yanagita, Koji Yamashita
  • Patent number: 7419790
    Abstract: It is intended to provide a sodium-independent transporter carrying an acidic amino acid and its gene. A protein having the amino acid sequence represented by SEQ ID NO: 1 and being capable of sodium-independently transporting an acidic amino acid and its analogs; a gene encoding this protein; a fused protein of the above protein with an auxiliary factor enabling the expression of its function; a gene encoding the same; a method of analyzing the function of a transporter using the same: and utilization thereof.
    Type: Grant
    Filed: August 18, 2004
    Date of Patent: September 2, 2008
    Assignee: J-Pharma Co., Ltd
    Inventors: Hitoshi Endou, Yoshikatsu Kanai